The federal judge overseeing the Covidien hernia mesh lawsuits said on November 10 that she will reduce the $88 million verdict from the first trial, saying the award appeared to be “the product of passion.”
U.S. District Judge Patti B. Saris made the comments at a hearing in Boston. She said the award was partly driven by a powerful closing argument, and she has not yet said how much she will cut it. Her decision will matter to the thousands of people with Covidien mesh claims, because the first verdict is one of the few real signs of how juries value these cases.
What the jury decided
In August, a Boston jury awarded $77 million to Larry Patterson, an Alabama man, and $11 million to his wife, Tammy, after a three week trial. Patterson received Covidien Symbotex mesh during a 2017 hernia repair and alleged that it led to a bowel obstruction that required another surgery in 2020. The jury found that Covidien, a Medtronic company, failed to adequately warn about the risks of the mesh. It did not award punitive damages. Our earlier story explains how the evidence about the mesh’s collagen coating shaped the verdict.
Medtronic said it disagreed with the verdict and would challenge it after trial. Among other things, it argued the award was far too high because Patterson was still able to work and carry on his daily activities.
What a reduced award means
When a federal judge decides that a jury’s award is too high, the usual step is to give the plaintiff a choice: accept a lower amount or go through a new trial on damages. The judge’s comments were about the size of the award, not about whether Covidien is responsible. She has not said she will set aside the jury’s finding that Covidien failed to warn.
For people with their own claims, the takeaway is the same either way. A verdict shows how one jury valued one case. It does not set what anyone else will receive, and each claim is valued on its own facts, such as the injury, the surgeries that followed and what the medical records show. Judge Saris has also urged the two sides to consider settling. No settlement has been announced.
The next Covidien trials
The cases are consolidated in multidistrict litigation, MDL No. 3029, in the U.S. District Court for the District of Massachusetts, where 2,486 lawsuits were pending as of November 2, 2026, according to the Judicial Panel on Multidistrict Litigation. Thousands more are pending in Massachusetts state court.
The next test trial, called a bellwether, is scheduled to begin January 11, 2027. It was brought by Regina Stephen and involves Covidien Symbotex mesh, the same product as the first trial. A trial involving Covidien ProGrip mesh is scheduled for March 29, 2027. Each trial adds another data point on how juries see the evidence.
Who may have a claim
The lawsuits involve Covidien hernia mesh products including Parietex, Symbotex and ProGrip. People who had one of these meshes and later needed surgery to repair or remove it, or who developed problems such as bowel obstruction, adhesions, chronic pain or infection, may have a claim for compensation. Many patients do not know which mesh they received; the operative report from the hernia surgery usually names it. Our sister site explains the Covidien Symbotex mesh lawsuits in more detail.
Doyle APC currently represents clients nationwide in Covidien hernia mesh lawsuits and is still reviewing select Bard claims with severe injuries.
Common Questions
What did the judge say about the $88 million verdict?
At a November 10, 2026 hearing, U.S. District Judge Patti B. Saris said she plans to reduce the award in the first Covidien hernia mesh trial, saying it appeared to be the product of passion. She has not yet said how much she will reduce it.
Does a lower award mean Covidien won?
No. The judge’s comments were about the size of the award. The jury found that Covidien failed to adequately warn about the risks of its Symbotex mesh, and she has not said she will set that finding aside.
When is the next Covidien hernia mesh trial?
The next test trial, brought by Regina Stephen over Covidien Symbotex mesh, is scheduled to begin January 11, 2027. A trial over ProGrip mesh is scheduled for March 29, 2027.
Will the verdict decide what other people receive?
No. A verdict shows how one jury valued one case. Each claim is valued on its own facts, such as the injury, the surgeries that followed and the medical records.
Can I still file a Covidien hernia mesh claim?
Yes. The federal litigation is open, and people can still file claims. Deadlines, called statutes of limitations, vary by state and often run from when an injury was discovered.




